Ian F. Smith
2012
In 2012, Ian F. Smith earned a total compensation of $3.1M as EVP & Chief Financial Officer at Vertex Pharmaceuticals, a 7% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $376,577 |
|---|---|
| Option Awards | $1,723,546 |
| Salary | $539,241 |
| Stock Awards | $457,379 |
| Other | $12,450 |
| Total | $3,109,193 |
Smith received $1.7M in option awards, accounting for 55% of the total pay in 2012.
Smith also received $376.6K in non-equity incentive plan, $539.2K in salary, $457.4K in stock awards and $12.5K in other compensation.
Rankings
In 2012, Ian F. Smith's compensation ranked 2,236th out of 11,487 executives tracked by ExecPay. In other words, Smith earned more than 80.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,236 out of 11,487 | 81st |
Division Manufacturing | 786 out of 4,252 | 82nd |
Major group Chemicals And Allied Products | 176 out of 1,200 | 85th |
Industry group Drugs | 101 out of 922 | 89th |
Industry Pharmaceutical Preparations | 82 out of 697 | 88th |
Source: SEC filing on April 30, 2015.
Smith's colleagues
We found six more compensation records of executives who worked with Ian F. Smith at Vertex Pharmaceuticals in 2012.
2012
Matthew Emmens
Vertex Pharmaceuticals
Chief Executive Officer
2012
Jeffrey Leiden
Vertex Pharmaceuticals
Chief Executive Officer
2012
Stuart Arbuckle
Vertex Pharmaceuticals
EVP & Chief Commercial Officer
2012
Peter Mueller
Vertex Pharmaceuticals
Chief Scientific Officer
2012
David Howton
Vertex Pharmaceuticals
Chief Legal Officer
2012
Kenneth Horton
Vertex Pharmaceuticals